Clinical experiences with the streptococcal anticancer preparation, OK-432 (NSC-B116209)
Kurokawa, T.; Hattori, T.; Furue, H.
Cancer ChemoTherapy Reports 56(2): 211-220
1972
ISSN/ISBN: 0069-0112 PMID: 4557736 Document Number: 45245
Document emailed within 1 workday
Related Documents
Lazecki, L. 1972: First clinical experiences with Endobil Bracco preparation used for infusion cholangiography Polski Przeglad Radiologii i Medycyny Nuklearnej 36(6): 771-774Bolcskei, P. 1980: New codeine depot preparation. Clinical experiences with a new codeine depot preparation Zfa. Zeitschrift für Allgemeinmedizin 56(18): 1263-1266
Jin, N.; Zhao, Y-Xing.; Deng, S-Hua.; Sun, Q. 2011: Preparation and in vitro anticancer activity of oxymatrine mixed micellar nanoparticles Die Pharmazie 66(7): 506-510
Kanzaki, N.; Terashima, M.; Kashimura, S.; Hoshino, M.; Ohtani, S.; Matsuyama, S.; Hoshino, Y.; Kogure, M.; Oshibe, I.; Endo, H.; Saito, T.; Yaginuma, H.; Gotoh, M.; Ohto, H. 2005: Understanding the response of dendritic cells to activation by streptococcal preparation OK-432 Anticancer Research 25(6b): 4231-4238
Fujita, K. 1988: Histological changes caused by intralesional injection of a streptococcal preparation into bladder cancer Cancer Detection and Prevention 11(3-6): 397-403
Yamamoto, A.; Nagamuta, M.; Usami, H.; Sugawara, Y.; Watanabe, N.; Niitsu, Y.; Urushizaki, I. 1986: Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1905-1910
Watabe, S.; Sendo, F.; Kimura, S.; Arai, S. 1984: Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432 Journal of the National Cancer Institute 72(6): 1365-1370
Fujimoto, T.; Duda, R.B.; Szilvasi, A.; Chen, X.; Mai, M.; O'Donnell, M.A. 1997: Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state Journal of Immunology 158(12): 5619-5626
Kurth, K.H.; Marquet, R.; Zwartendijk, J.; Warnaar, S.O. 1987: Autologous anticancer antigen preparation for specific immunotherapy in advanced renal cell carcinoma European Urology 13(1-2): 103-109
Yoshinaga, T.; Nomura, H.; Nishimura, H.; Tomino, S.; Kawakita, M.; Takatsuki, K.; Fujimoto, K.; Etou, Y.; Nakaji, T.; Kiyama, T. 1986: Production of a cytotoxic factor into malignant pleural fluid by OK-423, a streptococcal preparation--kinetic analysis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(8): 2675-2677
Saji, S.; Miya, K.; Oshita, H.; Nonomura, O.; Yokoyama, Y.; Yamamoto, S.; Takekoshi, T.; Sakata, K. 1982: Antitumor effect of intraperitoneal administration of a streptococcal preparation, OK-432, in carcinomatous peritonitis. I. Experimental study in the rat Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(11): 1961-1968
Chen, Y.; Lu, H.; Song, S.; Jia, X. 2010: Preparation of Ganoderma lucidum polysaccharides and triterpenes microemulsion and its anticancer effect in mice with transplant Heps tumors Zhongguo Zhong Yao Za Zhi 35(20): 2679-2683
Katano, M.; Yamamoto, H.; Hisatsugu, T. 1986: Management of malignant ascites with a streptococcal preparation, OK-432: induction of growth inhibition factor(s) against tumor cells Nihon Geka Gakkai Zasshi 87(4): 471
Pålsson, P.; Persson, E.K.; Ekelin, M.; Kristensson Hallström, I.; Kvist, L.J. 2017: First-time fathers experiences of their prenatal preparation in relation to challenges met in the early parenthood period: Implications for early parenthood preparation Midwifery 50: 86-92
Moriya, A.; Usami, E.; Hirose, T.; Takenaka, S.; Asano, H.; Okada, K.; Adachi, S.; Yoshimura, T. 2019: Examination of Actual Medical Material Cost and Cost Reduction Related to Exposure Prevention in the Preparation of Anticancer Drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(8): 1281-1286
Shimotsuma, M.; Simpson-Morgan, M.W.; Takahashi, T.; Hagiwara, A. 1992: Activation of omental milky spots and milky spot macrophages by intraperitoneal administration of a streptococcal preparation, OK-432 Cancer Research 52(19): 5400-5402
Ojima, T.; Iwahashi, M.; Nakamura, M.; Matsuda, K.; Nakamori, M.; Ueda, K.; Naka, T.; Katsuda, M.; Miyazawa, M.; Iida, T.; Yamaue, H. 2008: Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA International Journal of Oncology 32(2): 459-466
Leng, T.; Chay, S.O. 1982: A three-year streptococcal survey among Singapore school children: Part II. Streptococcal infections Annals of the Academy of Medicine Singapore 11(1): 101-109
Kossmann, C.E. 1981: Streptococcal sore throat--status of the streptococcal vaccine Journal of the Tennessee Medical Association 74(4): 269-274; 276
Eckardt, J.; Eckhardt, G.; Villalona-Calero, M.; Drengler, R.; Von Hoff, D. 1995: New anticancer agents in clinical development Oncology 9(12): 1321-1328; 1331; Discussion: 1332-1334